Scientists are fighting for their halted funds. Trust of Black communities may be harder to win back
The Pittsburgh project was cut off in its fifth and final year, when it was near completion. NIH withdrew funding, leaving participants without answers about what their memory and other tests showed. The study followed people in the historically Black Hill and Homewood communities. Over four years, participant Roderick Blair took memory tests, while researchers tracked sleep and blood pressure and collected participants’ stories. Researchers were examining why Black Americans are twice as likely as white peers to develop Alzheimer's disease. The funding halt meant the team could not finish the work as planned or share findings with participants. Researchers say the decision wasted more than $8 million already spent and damaged trust built through years of community engagement. They also say the study had undergone rigorous review and vetting by a community advisory board.
What happened to the Pittsburgh Alzheimer's study, and how close was it to completion?
The Pittsburgh project was cut off in its fifth and final year, when it was near completion. NIH withdrew funding, leaving participants without answers about what their memory and other tests showed.
The study followed people in the historically Black Hill and Homewood communities. Over four years, participant Roderick Blair took memory tests, while researchers tracked sleep and blood pressure and collected participants’ stories. Researchers were examining why Black Americans are twice as likely as white peers to develop Alzheimer's disease.
The funding halt meant the team could not finish the work as planned or share findings with participants. Researchers say the decision wasted more than $8 million already spent and damaged trust built through years of community engagement. They also say the study had undergone rigorous review and vetting by a community advisory board.
How much funding had already been spent on the halted Pittsburgh studies?
Researchers said more than $8 million in taxpayer money had already been spent on the Pittsburgh study before NIH stopped its funding. That is the article’s figure for money spent on the study that was near completion.
A separate, complementary Pittsburgh Alzheimer's-risk study led by Ann Cohen was also halted, after spending $5.2 million over three years. Cohen is part of the lawsuit challenging NIH's actions. The article describes these as separate studies, so the two figures should not be treated as one reported total.
The money had supported research involving participants and the collection of information about memory, sleep, blood pressure and personal histories. Researchers say the termination left work unfinished and raised questions about how to handle participants’ blood samples. The figures show the scale of funding spent before two Pittsburgh research efforts were stopped.
Why did NIH say the studies were not scientific, and what reasons do researchers give for challenging that decision?
The article reports that NIH terminated the Pittsburgh study on the grounds that it was “not science.” Negar Fani’s grant was also described as “not scientific” and “subjective.” A spokesperson for the Department of Health and Human Services said many DEI grants had failed to translate into better health outcomes and that NIH was shifting money toward rigorous research.
Researchers challenge those characterizations. The Pittsburgh study had undergone rigorous review and vetting by a community advisory board, and it was near the end of its fifth year. Fani said her project was brain science research, studying how daily experiences of racial discrimination affect the brain and body.
Fani’s study had been approved and had enrolled 66 of its planned 220 participants when it was terminated. Researchers also note that the grants were already underway before funding was cut. They are seeking to challenge the decisions through legal action, while Fani tries to find money to complete her project.
What may participants and the wider community lose when a long-term study ends before sharing its results?
When a long-term study ends before its results are shared, participants may be left without answers about what their own tests showed. In Pittsburgh, people had contributed time and personal information while researchers investigated Alzheimer's risk. Researchers say participants may never learn if their brain tests showed signs of trouble.
The study also helped start conversations about memory loss, dementia and Alzheimer's in Hill and Homewood. Field coordinator La'Vette Wagner said families who once dismissed memory loss as depression began asking about dementia. People outside the study also called to ask whether family members could join.
Researchers worry that stopping the work could undo some of that engagement and deepen distrust. Roderick Blair said participants may feel researchers came, collected information and left them hanging. Scientists say trust takes time to build and can be lost much faster. The halt also leaves researchers with questions about collected blood samples and unfinished findings.
What is the National Institutes of Health, and how does it fund medical research?
The National Institutes of Health, or NIH, is a U.S. government agency that supports and conducts health and medical research. The article identifies NIH as the funder of the Pittsburgh and Fani studies and describes it as part of the Department of Health and Human Services.
In general, NIH supports outside research teams through grants. Researchers apply with a proposed project, and applications are typically assessed through scientific review before awards are made. Grant funding can support research costs over multiple years. This explanation of the usual process is established background; the article does not describe the application or review steps for these specific grants.
In the cases described, NIH terminated funding after the projects had begun. The Pittsburgh study was in its final year, while Fani’s five-year project had enrolled 66 of 220 planned participants. Researchers say they are trying to challenge the terminations or find other money to complete the work.
What is Alzheimer's disease, and what kinds of information can researchers study to understand who is at risk?
Alzheimer's disease is a progressive brain disease that affects memory and other thinking abilities. This basic description is established background; the article itself focuses on who may be at risk. It reports that Black Americans are twice as likely as their white peers to develop Alzheimer's.
The Pittsburgh researchers gathered several kinds of information from participants: memory-test results, sleep, blood pressure and stories about their past. These measures let researchers examine health and life experiences alongside memory, as they tried to understand risk. A separate project by Negar Fani examined how daily experiences of racial discrimination affect the brain and body of Black Americans.
The article does not report the studies’ findings, because funding was halted before the research could be completed and shared. It also describes how the work encouraged conversations about dementia and memory loss. Completing such research could help answer questions about risk, but the article provides no final results or conclusions.
What happened in the Tuskegee study, and why does its legacy still shape trust in health research?
The Tuskegee study involved Black men infected with syphilis in the 1930s, and treatment was withheld from them. The article names this history as one reason trust in U.S. health institutions has long been strained in the Black community.
That legacy sits alongside broader problems the article identifies: racial health inequities, unequal access to care and bias in the medical system. These experiences shape how communities may interpret research and the actions of health institutions. The Pittsburgh researchers had to build relationships before people took part in the study.
The Pittsburgh project had gained participation in historically Black Hill and Homewood, and its work helped prompt discussion of memory loss and dementia. Researchers say the abrupt funding halt risks harming that trust. La'Vette Wagner described the study as real work in the community, while Negar Fani said restoring trust after repeated betrayals takes a great deal of effort.
This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.
Read more in the JupiteX app
Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.
Or read more news on the web